By Lina carolina 
A groundbreaking study by researchers at the University of Cologne and the Centre for Genomic Regulation (CRG) in Barcelona has fundamentally challenged long-held assumptions about how cancer grows and spreads. Published today in the esteemed journal eLife, the research indicates that tumors do not, as previously theorized, expand primarily from their outer edges. Instead, this extensive investigation reveals that cancer masses grow uniformly throughout their entire volume, with every region exhibiting equal activity and possessing the potential to harbor aggressive mutations. This paradigm shift has profound implications for our understanding of tumor evolution, treatment strategies, and the development of resistance to therapies.
Decades-Old Assumptions Challenged
For over half a century, the prevailing scientific hypothesis posited that tumors operated as "two-speed" entities. This model suggested that the periphery of a tumor, with its closer proximity to vital blood vessels, enjoyed a privileged status. Cells at the outer edges were believed to have superior access to oxygen and nutrients, facilitating rapid division and proliferation. Conversely, the core of the tumor, increasingly distant from these life-sustaining resources and subjected to greater mechanical pressure, was thought to be a region of slower cellular activity and diminished growth potential. This "surface growth" model painted a picture of a tumor expanding outwards, like a ripple in a pond.
The implications of this long-standing theory were significant. It informed approaches to cancer treatment, suggesting that targeting the more active peripheral cells might be the most effective way to halt tumor progression. It also shaped the understanding of how tumors might develop resistance to therapies, with the assumption that mutations conferring such resistance would likely arise and proliferate in these rapidly dividing outer cells.
The Spatial Genomics Revolution
The recent findings from the University of Cologne and CRG collaboration directly confront this established narrative. The researchers employed a sophisticated technique known as spatial genomics, a powerful tool that allows scientists to analyze the genetic makeup of cells within their precise spatial context in a tissue. This methodology was crucial in providing an unprecedented level of detail about the genetic landscape of tumors.
The study drew upon data from prior research, which had meticulously collected hundreds of small tissue samples from diverse locations within liver tumors. These samples were analyzed in both two- and three-dimensional space, creating a comprehensive and detailed genetic map of the tumor’s interior. This extensive data set enabled the researchers to move beyond broad assumptions and delve into the intricate patterns of genetic mutations that drive cancer’s progression.
Unraveling the Growth Pattern
The core of the study involved a meticulous examination of the mutations found within each sampled region of the tumors. The research team developed an innovative method to quantify the directionality and spread of these mutations. By calculating the angles between the positions of "parent" cells and their subsequently mutated "offspring," they aimed to discern the underlying growth dynamics.
In a scenario consistent with the surface growth model, one would expect these calculated angles to predominantly point outwards, indicating a directional expansion from the tumor’s core towards its periphery. However, the results presented a starkly different picture. The angles of mutation spread were found to be distributed evenly in all directions. This uniform dispersal strongly suggests that cell division and, consequently, tumor growth, are occurring simultaneously throughout the entire tumor mass, not just at its edges.
Mutation Distribution: A Uniform Landscape
Further reinforcing the concept of uniform growth, the study also analyzed the spatial distribution of mutations within the tumor. If cancer cells were indeed growing predominantly at the periphery, a clustering of mutations would be expected in these outer regions. Conversely, the researchers observed that mutations were widely dispersed across the tumor volume. This widespread distribution is a clear indicator that cell division is a pervasive process occurring in all areas of the tumor, from the center to the edges.
Computational Validation: Reinforcing the Evidence
To bolster their empirical findings and further validate their conclusions, the researchers utilized advanced computational simulations. They constructed virtual tumor models, deliberately creating two distinct scenarios: one based on the traditional surface growth hypothesis and another reflecting the newly proposed uniform volume growth model.
The patterns of mutations generated by these virtual tumors were then meticulously compared to the patterns observed in the real tumor data. The results were compelling: the mutation patterns in the actual liver tumors closely mirrored those generated by the volume growth simulations, while exhibiting significant discrepancies with the surface growth simulations. This computational validation provides robust support for the conclusion that tumors grow uniformly from within.
Implications for Tumor Evolution and Therapy
The discovery that tumors grow uniformly has profound implications for our understanding of cancer evolution. Professor Johannes Berg, a co-corresponding author of the study from the University of Cologne, explained, "Our findings have implications for tumour evolution. The constant churn of cells dying and being replaced by new ones throughout the tumour volume gives cancer many opportunities for evolutionary innovations, such as escaping from immune surveillance."
This continuous cellular turnover, occurring throughout the tumor’s mass, provides ample opportunities for cancer cells to acquire new mutations. These mutations can lead to the development of novel traits, including the ability to evade the immune system, a critical mechanism by which cancer progresses and resists treatment.
Dr. Donate Weghorn, the other co-corresponding author from the Centre for Genomic Regulation in Barcelona, elaborated on the significance of this uniform growth. "We challenge the idea that a tumour is a ‘two-speed’ entity with rapidly dividing cells on the surface and slower activity in the core," she stated. "Instead, we show they are uniformly growing masses, where every region is equally active and has the potential to harbour aggressive mutations."
This insight suggests that any region of the tumor, not just the periphery, could potentially harbor cells with the capacity to drive aggressive disease progression or develop resistance to therapies. This necessitates a re-evaluation of how we conceptualize and target tumors in clinical settings.
Limitations and Future Directions
While the findings represent a significant leap forward, the researchers acknowledge certain limitations. The study primarily focused on liver cancer, and it is crucial to investigate whether these uniform growth patterns hold true for other types of cancer. Different tumor microenvironments and cellular compositions across various cancer types may influence growth dynamics.
Furthermore, the study’s insights are largely centered on the early stages of tumor growth. The behavior of larger, more established tumors, or those that have metastasized, may differ. The complex interplay of factors in advanced cancers, such as extensive necrosis, altered vascularization, and invasion into surrounding tissues, could potentially modify growth patterns.
Dr. Berg highlighted the importance of extending this research to later stages of tumor development: "The emergence of mutants that confer resistance to therapy are an important aspect of clinical relevance. Our work focuses on early-stage tumour growth, but expanding the research to late-arising mutations can tell us more about those mutations and why they ultimately foil many therapeutic approaches."
Future research will likely focus on applying spatial genomics to a broader range of cancer types and stages. Investigating the genetic and environmental factors that contribute to uniform growth, as well as exploring how this uniform growth model impacts the development of drug resistance and immune evasion in advanced cancers, will be critical next steps. The hope is that a deeper understanding of these fundamental growth mechanisms will pave the way for more effective and personalized cancer therapies.
A Paradigm Shift in Cancer Research
The work by the University of Cologne and CRG represents a pivotal moment in cancer biology. By challenging a foundational assumption and providing robust, data-driven evidence for a new model of tumor growth, these researchers have opened up new avenues of inquiry. This shift from a peripheral-centric view to a uniform, volume-based understanding of cancer proliferation necessitates a re-examination of existing therapeutic strategies and holds the promise of unlocking more effective ways to combat this complex disease. The scientific community will undoubtedly be closely watching as this new paradigm is further explored and its full implications are realized.